Cite

HARVARD Citation

    Basali, D. et al. (2020). Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma. British journal of haematology. pp. 1136-1140. [Online]. 
  
Back to record